UNSPSC 51386602: Aloe/hydrocortisone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE200. This VA Drug Class (DE200) classifies this compound as belonging to the group ANTI-INFLAMMATORY, TOPICAL.

UNSPSC 51386602 Aloe/hydrocortisone is a Commodity code for pharmaceutical topical preparations, but the most recent state and local solicitation activity under this code shows a material mismatch: Seminole County, Florida posted an IFB for naloxone and drug deactivation systems, neither of which align with the code's nominal scope of aloe or hydrocortisone products. The source provides no recent opportunities for actual aloe or hydrocortisone procurement. State and local governments using this code are expected to buy over-the-counter and prescription topical treatments for wound care, dermatological conditions, and related clinical applications through routine competitive bidding processes, but the single recent posting tagged to this code does not reflect that scope.

Seminole County is the only issuing body with a recent opportunity listed under this code. The county's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida, with an initial two-year term and one-year renewal option. The miscoding of this naloxone and drug deactivation procurement under a code nominally reserved for aloe/hydrocortisone suggests either a data-entry error or a broader indexing issue. Until additional relevant opportunities appear, this code shows no active state and local procurement demand for its intended pharmaceutical product category.